BOTH MRI AND HAQ-DI CAN PREDICT RELAPSES FOLLOWING ALL TREATMENT WITHDRAWAL IN MTX-NAIVE PATIENTS WITH RA IN REMISSION AFTER 12 MONTHS OF ABATACEPT THERAPY IN THE AVERT TRIAL
Author(s):
Ahmad, H.; Baker, J.; Ostergaard, M.; Emery, P.; Huizinga, T.; Ye, J.; Banerjee, S.; Conaghan, P.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 240-240
